Letter to the Editor: AMBAR: A Therapeutical Approach for Alzheimer's Disease Patients Regardless of Amyloid Status
J Prev Alzheimers Dis
.
2023;10(1):148-149.
doi: 10.14283/jpad.2022.100.
Authors
M Costa
1
,
M Boada
Affiliation
1
Montserrat Costa, Ph.D., Grifols Scientific Innovation Office, Carrer Palou, 3, 08150 Parets del Vallès, Barcelona, Spain, Tel: (+34) 935710853; Fax: (+34) 935710855, E-mail: montse.costa@grifols.com.
PMID:
36641621
DOI:
10.14283/jpad.2022.100
No abstract available
Publication types
Letter
Comment
MeSH terms
Alzheimer Disease* / drug therapy
Amyloid
Amyloid beta-Peptides
Humans
Methacrylates
Substances
Amyloid
Amyloid beta-Peptides
Methacrylates